According to filings with the U.S. Securities and Exchange Commission, Digital Therapeutics dba Pelago is raising up to $50,499,903.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Yusuf Sherwani played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Digital Therapeutics dba Pelago
Pelago is the worlds leading virtual clinic for substance use management. We are transforming substance use support from prevention to treatment delivering education, management skills, and opportunities for positive change to members struggling with substance use, most commonly tobacco, alcohol, or opioids. Our solution gives employers the means to offer on-demand, personalized support to workers seeking to live healthier lives. Pelagos cognitive behavioral therapy (CBT) and medication-assisted treatment (MAT) programs deliver convenient, accessible, and effective support that seamlessly integrates with health plans, pharmacy benefit managers, and wellness platforms. To date, Pelago has helped more than 750,000 members manage their substance use and improve their lives. Visit www.pelagohealth.com for more information.

To learn more about Digital Therapeutics dba Pelago, visit http://www.pelagohealth.com/

Contact:
Yusuf Sherwani, Chief Executive Officer
877-349-7755
https://www.linkedin.com/in/ysherwani/

SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.